Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;3(3):e426.
doi: 10.52225/narra.v3i3.426. Epub 2023 Dec 22.

A pediatric case and literature review of mucormycosis: Diagnostic and treatment challenges in a resource poor setting

Affiliations

A pediatric case and literature review of mucormycosis: Diagnostic and treatment challenges in a resource poor setting

Inke Nd Lubis et al. Narra J. 2023 Dec.

Abstract

Mucormycosis is an emerging disease that primarily affects immunocompromised patients; however, it has also been reported in immunocompetent individuals. Studies in the pediatric population are limited and reported mostly in case studies or series. The aim of this case report is to present a pediatric mucormycosis originated from Sumatra Island, Indonesia. A 13-year-old boy was referred to a tertiary hospital with facial necrosis involving the nasal, oral, and left maxillary areas, as well as left periorbital edema. No known underlying conditions were documented. The diagnosis was confirmed by histopathological findings of broad, pauci-septate, ribbon-like hyphae branching at 90°. The patient was managed by a multidisciplinary team consisting of the ear, nose, and throat, infectious diseases, dermatology, surgery, microbiology, and pathology departments. Management of the patient included debridement of the necrotic lesion and antibiotics and anti-fungal (fluconazole). Due to unavailability, the patient was not treated with amphotericin B. The patient died after 30 days of admission. This case highlights the importance of maintaining a high suspicion of invasive mucormycosis, even in immunocompetent children, when symptoms and signs are present, especially in resource-limited settings.

Keywords: Mucorales; Mucormycosis; immunocompetent; invasive fungal infection; pediatric case.

PubMed Disclaimer

Conflict of interest statement

All the authors declare that there are no conflicts of interest.

Figures

Figure 1.
Figure 1.. Progress of infection. (A) At 4 months since the first symptom. (B) At 8 months and on admission to the hospital. (C) Post debridement.
Figure 2.
Figure 2.. Histopathological findings showing broad, pauci-septate, ribbon-like hyphae branching at 90° with inflammatory cells (HE stain).

References

    1. Mahalaxmi I, Jayaramayya K, Venkatesan D, et al. . Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res 2021;201:111643. - PMC - PubMed
    1. Gomes MZR, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 2011;24(2):411–445. - PMC - PubMed
    1. Jeong W, Keighley C, Wolfe R, et al. . Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports. Int J Antimicrob Agents 2019;53(5):589–597. - PubMed
    1. Skiada A, Lass-Floerl C, Klimko N, et al. . Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 2018;56 Suppl 1:93–101. - PMC - PubMed
    1. Pana ZD, Seidel D, Skiada A, et al. . Invasive mucormycosis in children: An epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis 2016;16(1):667. - PMC - PubMed

LinkOut - more resources